<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>건강과 대안 &#187; 소비자 인식</title>
	<atom:link href="http://www.chsc.or.kr/tag/%EC%86%8C%EB%B9%84%EC%9E%90%20%EC%9D%B8%EC%8B%9D/feed" rel="self" type="application/rss+xml" />
	<link>http://www.chsc.or.kr</link>
	<description>연구공동체</description>
	<lastBuildDate>Mon, 13 Apr 2026 01:34:28 +0000</lastBuildDate>
	<language>ko-KR</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>[보사연]가정상비약에 대한 소비자 인식 조사결과</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=3093</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=3093#comments</comments>
		<pubDate>Tue, 11 Oct 2011 11:19:45 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[가정상비약]]></category>
		<category><![CDATA[소비자 인식]]></category>
		<category><![CDATA[의약품 수퍼판매]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=3093</guid>
		<description><![CDATA[가정상비약에 대한 소비자 인식 조사결과 보사연 보건복지 이슈앤포커스 제107호 (2011-39) 발행일 : 2011. 10. 07 - 국민들이 가정상비약을 구입할 때‘야간이나 공휴일에 구입이 곤란하다 ’는 응답자가&#160;61.4%를 차지하였음 - 가정상비약을 [...]]]></description>
				<content:encoded><![CDATA[<p>가정상비약에 대한 소비자 인식 조사결과
<div>보사연 보건복지 이슈앤포커스</div>
<div>제107호 (2011-39) 발행일 : 2011. 10. 07</div>
<p>
<div>
<div>- 국민들이 가정상비약을 구입할 때‘야간이나 공휴일에 구입이 곤란하다 ’는 응답자가&nbsp;61.4%를 차지하였음</div>
<div>- 가정상비약을 구입할&nbsp;때 야간이나 공휴일에&nbsp;약국이 문을 닫아 불편&nbsp;함을 경험한 응답자는&nbsp;78.3%였음</div>
<div>- 가정상비약을 약국 이외의 장소에서 판매하는 것에 대해 83.2%가&nbsp;찬성하였음</div>
<div>- 지난 1년 동안 가정상비약을 사용하다가 본인이 부작용을 경험한&nbsp;적이 있었던 응답자는&nbsp;29명(2.9%)으로 나타났음</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=3093/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[GMO] Biotechnology: What&#8217;s in a Name?</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=1221</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=1221#comments</comments>
		<pubDate>Sun, 01 Nov 2009 15:19:56 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[GMO]]></category>
		<category><![CDATA[과학기술 · 생의학]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[Thomas J. Hoban]]></category>
		<category><![CDATA[생명공학]]></category>
		<category><![CDATA[소비자 인식]]></category>
		<category><![CDATA[유전자조작]]></category>
		<category><![CDATA[홍보전략]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=1221</guid>
		<description><![CDATA[바이오케크놀로지(생명공학)이라는 용어 속에 담긴 이미지는 긍정적인 이미지입니다.이것은 유전자조작 업계와 그를 후원하는 미국 정부의 홍보전략이 담긴 용어이도 합니다.이 논문은 유전자조작 업계의 그러한 홍보전략을 엿볼 수 있는 자료입니다.===================== (이 글은 [...]]]></description>
				<content:encoded><![CDATA[<p><P>바이오케크놀로지(생명공학)이라는 용어 속에 담긴 이미지는 긍정적인 이미지입니다.<BR>이것은 유전자조작 업계와 그를 후원하는 미국 정부의 홍보전략이 담긴 용어이도 합니다.<BR>이 논문은 유전자조작 업계의 그러한 홍보전략을 엿볼 수 있는 자료입니다.<BR><BR>===================== (이 글은 참고용으로 제가 작성한 것입니다.) ===========<BR><BR><!--StartFragment-->일부 언론과 전문가들은 광우병은 과학적 용어가 아니기 때문에 우 해면상 뇌증(BSE)이라는 전문 용어를 사용해야 한다고 주장하고 있다. 그러나 광우병이나 우 해면상 뇌증은 모두 원인을 모른 상태에서 눈에 보이는 증상을 그럴듯하게 표현한 것에 불과할 뿐이다. 다시 말해 불확실성에 대한 대중적 표현과 전문가적 표현은 실질적으로 크게 차이가 없다고 볼 수 있다.</P><br />
<P>이와 비슷한 사례는 조류 독감과 조류 인플루엔자(AI), 유전자 조작 식품(GMO)과 생명 공학(Bio-technology)과 같은 용어 사용에서도 찾아 볼 수 있다. 정부와 기업은 대중적으로 널리 쓰이고 있는 ‘조류 독감’이라는 용어는 비과학적 용어이기 때문에 ‘조류 인플루엔자(AI)’라는 용어를 쓸 것을 언론에 권장해왔다. 그러나 인플루엔자(Influenza)의 어원은 이탈리아 어로 ‘추위의 영향(influenza di freddo)’이라는 뜻이다. 대중은 독감이 겨울의 추운 바람이나 봄의 차가운 기운 때문에 발생한다고 믿어 왔다. 따라서 독감과 인플루엔자는 모두 불확실성을 대중적 용어와 전문적 용어로 비슷하게 표현한 것일 뿐 어느 것이 더 과학적이라고 단정적으로 이야기할 수 없다. </P><br />
<P>실제로 정부와 기업이 대중들이 쉽게 이해하기 힘든 용어로 병명을 붙이는 이유는 바로 경제적인 이유 때문이다. 지난 2005년 11월, 국회에서 있었던 조류 독감 토론에서 모 교수는 “일부 전문가 및 매스컴에서 아직까지도 조류 독감이라고 부르고 있는데, 조류 인플루엔자로 해야 한다. 왜냐하면, 조류 독감이라고 했을 경우 일반 국민이 갖게 되는 공포심은 자칫 가금(닭, 오리) 산업, 나아가서 국내 농식품 산업 전반에 좋지 않은 영향을 미칠 수도 있기 때문이다.”라며 속마음을 솔직하게 드러내기도 했다. </P><br />
<P>GMO는 유전자(Genetically)를 변형시킨(Modified) 유기체(Organism)라는 뜻이다. 그런데 대중들이 유전자 조작이라는 용어에 부정적인 인식을 가지고 있기 때문에 정부와 기업은 새로운 홍보 전략을 세웠다. 기업의 후원을 받은 소비자심리학 전문가들은 유전자조작, 유전자공학, 생명공학 등의 용어들에 대한 소비자들의 인식과 수용태도를 조사했다. 그 결과 소비자들에게 긍정적 인식을 줄 수 있는 생명공학(Bio-technology)이란 용어를 찾아낸 것이다. ‘바이오테크놀로지’라는 말은 1917년 헝가리 공학자인 카를 이레키가 처음 사용했는데, 1980년대 들어서 유전자조작 식품이 상업화된 이후 새롭게 주목을 받는 용어가 되었다. 이제 정부와 기업에게는 전문가들을 동원해 유전자 조작 식품이라는 용어는 부정적인 뉘앙스의 비과학적인 용어이기 때문에 생명 공학이라는 가치중립적인 전문 용어를 사용하자고 언론과 대중을 유혹하는 일만 남게 된 것이다. 하지만 곰곰이 생각해 보면 유전자를 변형시키고 조작하는 기술을 통해 새로운 동물, 식물, 미생물 같은 유기체를 만들어 내는 기술은 생명 공학이라는 용어보다는 유전자 조작이라는 용어가 더 잘 어울린다는 생각이다. 왜냐하면 때로는 가치 중립적인 용어가 새로운 과학 기술이나 질병의 위험이나 본질을 은폐하는 역할을 할 수도 있기 때문이다.</P><br />
<CENTER><B>===========================================================<BR><BR>Biotechnology: What&#8217;s in a Name?<br />
<P>A Paper Presented to the Southern Association of Agricultural Scientists <BR>Agricultural Communications Section <BR>Mobile, AL <BR>February 2003 </B></CENTER><br />
<P><A href="mailto:jdmiller@uark.edu">Jefferson D. Miller</A> <BR>Assistant Professor <BR>University of Arkansas<br />
<P><A href="mailto:mamane@uark.edu">Mamane Annou</A> <BR>Research Associate <BR>University of Arkansas<br />
<P><A href="mailto:ewailes@uark.edu">Eric J. Wailes</A> <BR>Professor <BR>University of Arkansas <BR><br />
<P><B>출처 : <A href="http://agnews.tamu.edu/saas/2003/miller_.htm">http://agnews.tamu.edu/saas/2003/miller_.htm</A><BR><BR>Background</B><br />
<P>One of the most significant dilemmas among agricultural communications researchers and practitioners lately is how best to inform and educate the public about agricultural biotechnology. As with previous technological advances of national and international importance involving public perceptions of risk, mass media play an important role in the public?s attitude regarding agricultural biotechnology. Hoban and Kendall (1996) advised that public communication and education is especially vital to public acceptability of agricultural biotechnology because people perceive the technology to affect the food they eat.<br />
<P>Researchers internationally in both academe and industry have been working on this communications dilemma since the mid-1980s. Survey and focus group research to determine public opinions about biotechnology-related issues has been common and has served to guide public communications and education efforts about biotechnology in the food and agriculture industry. This body of research points to two important premises: (1) Mass media play a key role in developing public opinion regarding biotechnology (Gaskell et al., 1999; Gunter, Kinderlerer, &#038; Beyleveld, 1999; Priest, 2000; IFIC, 2001, Marks, 2001); and (2) Though both consumers and journalists are becoming more informed (IFIC, 2001; Vestal and Briers, 2000), they generally have limited knowledge on which they can form their own attitudes about biotechnology, so they rely on peripheral cues to help in forming opinions (Wasnik and Kim, 2001). This second premise conforms to the Elaboration Likelihood Model (ELM) of Persuasion developed by Petty and Cacioppo (Nai-Hwa, 2001).<br />
<P>The ELM demonstrates a commonly applied theory of information processing and persuasion that when consumers can?t or won?t make decisions based on a sound understanding of a new technology, they resort to peripheral cues. These cues are small bits of information not necessarily related to scientific facts about the technology but nonetheless memorable and understandable to the lay consumer. The simplicity of the cues makes them easy to apply in the opinion-forming process.<br />
<P>In the case of biotechnology, one key peripheral cue for consumers may be the connotations associated with the name of the technology. In other words, as Wasnik and Kim (2001) suggest, consumers may form opinions according to their linguistic evaluation of the word used to symbolize biotechnology and food products resulting from biotechnology. This poses obvious problems for public communicators and educators, but it also causes potential problems for public opinion and public perception researchers, who must ensure that the connotations of the terms used in their survey questions and focus group discussion schedules don?t affect the tone of participants? responses.<br />
<P>Recent studies point to the importance of linguistics in determining public perceptions of biotechnology. In their analysis of biotechnology marketing, Wasnik and Kim (2001) concluded the following: &#8220;Biotechnology is a branding issue. It is providing a clear, systematic, vivid, focused message that is potentially important to consumers ? the powerful visuals that are associated with names such as &#8220;FrankenFoods&#8221; and &#8220;Super Weeds&#8221; leave little wonder why the public is able to latch on to such bumper-sticker philosophies of skeptics and be moved&#8221; (p. 10). Wasnik and Kim (2000) also reported on a 1991 European survey that found twice as many respondents thought that &#8220;genetic engineering&#8221; would make their lives worse than those who thought &#8220;biotechnology&#8221; would (p. 18).<br />
<P>Additionally, focus group research by Levy and Derby (2000) concluded that consumers in Maryland, Vermont, Washington, and Missouri found the terms &#8220;genetically engineered,&#8221; &#8220;genetically modified,&#8221; and &#8220;bioengineered&#8221; to be reasonably descriptive. However, the researchers also reported that connecting the concept of engineering with food had negative implications for some participants, that the term &#8220;modification&#8221; was seen as a vaguer, softer way of saying engineered, and that the &#8220;bio&#8221; sparked positive images for some participants. Terms such as &#8220;product of biotechnology,&#8221; or &#8220;bio technology&#8221; had the least amount of negative implication, while acronyms such as GM and GE were unfamiliar to most participants and were not viewed favorably by participants. Most participants were unfamiliar with the term &#8220;genetically modified organism&#8221; and considered it to be an inappropriate name for bioengineered foods, possibly because it implied that foods are organisms or contain organisms, which some people think is inaccurate and unappealing.<br />
<P>Also, in a recent survey of college students? perceptions, Sohan, Waliczek, and Briers (2002), found that students? unfamiliarity with technical terminology affected their responses to survey questions about biotechnology.<br />
<P>The results of these recent studies imply that inconsistent and unfamiliar terminology in public communications and in public perception survey instruments is problematic. Even a cursory glance at news articles, journal articles, and survey instruments related to biotechnology would reveal that there is no agreed-upon lexicon for the concept of biotechnology and its many applications among communicators, educators, and public perception researchers.<br />
<P>Purpose and Objectives<br />
<P>Because consumers lean heavily on mass media for information to help them form opinions about biotechnology, an analysis of the relationship between terminology and tone in mass communication efforts could lead to a better understanding of how terminology affects consumer perceptions. The purpose of this study was to build upon previous research about terminology related to biotechnology in working toward a common lexicon that can be applied more purposefully in public communications and survey research efforts. The study was guided by the following objectives:<br />
<BLOCKQUOTE><br />
<P>1. Analyze textual content from agricultural biotechnology-related articles in selected national and regional newspapers and trade publications to determine primary issues addressed and overall tone of the article. </P><br />
<P>2. Determine the terminology used in the articles? first reference to biotechnology or biotechnology-related products. </P><br />
<P>3. Determine possible relationships between the various terms most commonly used in first references to biotechnology and the perceived tone of the article. </P></BLOCKQUOTE><br />
<P><B>Method</B><br />
<P>Initial Qualitative Analysis<br />
<P>A purposively selected collection of 137 articles was developed, including articles from three national news publications?The Washington Post, USA Today, and the New York Times; one regional news publication&#8211;The Des Moines Register; three national agricultural trade publications&#8211;Farm Journal, Progressive Farmer, and Soybean Digest; one regional agricultural trade publication&#8211;Delta Farm Press; and one agricultural marketing trade publication&#8211;Agri Marketing. To be eligible for this study, an article must have contained some mention of agricultural biotechnology or products of agricultural biotechnology. The selected articles included opinion pieces and commentaries, news reports, and feature stories. Articles examined appeared in print between January 1, 2000 and July 1, 2002.<br />
<P>An initial qualitative analysis, which involved a team of coders working to develop a visual hierarchy of major themes, characteristics and definitions, led to development of a coding sheet to be employed by three trained coders. Emergent themes included Tone (positive, negative and neutral), Balance (balanced or not balanced), Length (number of words in article), Section (e.g., News, Business, Real Estate, Agriculture), Sources (people or organizations referred to or quoted in the article), Central Issues (socio-economic, political, and physical science), Secondary Issues (specific topics related to the central issue) and First-Reference Terminology (e.g., biotechnology, genetically engineered, or genetically modified).<br />
<P>For the purposes of this study, only information from the Central Issues, Tone, and First Reference Terminology categories were analyzed to determine relationships. Definitions for these characteristics agreed upon by the coders were the following:<br />
<P>Central Issue: The overarching theme under which the majority of information in the article fits.<br />
<P>Tone: The extent to which an article as a whole, through rhetorical stance, approves or disapproves of biotechnology.<br />
<P>First Reference Terminology: The first mention in an article of biotechnology or of concepts related to biotechnology. (Popular terms and their close variations were grouped. For example, &#8220;genetic modification&#8221; was grouped with &#8220;genetically modified.&#8221;)<br />
<P>Coder Training and Interrater Reliability<br />
<P>Three coders each read the first 50 randomly selected articles in sets of 10, using the coding sheet to characterize each article. The coders compared and discussed their characterizations at length, working toward consensus on the characterization of each article, until their characterizations reached an acceptable level of agreement (k=.80) according to Cohen?s (1960) index of interrater reliability.Acceptable agreement occurred at the conclusion of the fifth rating session. With a clear understanding of the group?s consensus, two of the three coders characterized the balance of the articles. Frequent discussions and peer critiques among the coders helped to further ensure interrater reliability.<br />
<P>Frequencies of codes related to tone, issues, and first-reference terminology were recorded and analyzed for emerging patterns and relationships. The results constituted the findings of this study.<br />
<P><B>Results</B><br />
<P>Primary Issues Addressed<br />
<P>Socio-economic issues dominated the selection of articles. Nearly half of the 137 articles focused on a broad range of issues under this category. Among them were numerous articles related to consumer and producer costs and benefits, agricultural industry concerns and actions, and environmental concerns. Political issues were second in frequency and focused on regulation, public opinion, and international politics. A relatively smaller number of the articles fit into the physical science category, which included stories about genetic science methods and biotechnology products.<br />
<P>Overall Tone Characteristics<br />
<P>Seventy percent of the 137 articles were positive or neutral in tone, with 36% coded as having a positive rhetorical stance with regard to biotechnology and 34% coded as neutral. Thirty percent were coded as having a negative tone toward biotechnology.<br />
<P>Table 1</P><br />
<P>Overall tone of biotechnology articles (N=137).</P><br />
<P><br />
<TABLE borderColor=#008000 cellSpacing=2 width=352 border=1><br />
<TBODY><br />
<TR><br />
<TD vAlign=top width="27%" height=6><br />
<P></P></TD><br />
<TD vAlign=top width="18%" height=6><br />
<P align=center>Positive</P></TD><br />
<TD vAlign=top width="18%" height=6><br />
<P align=center>Neutral</P></TD><br />
<TD vAlign=top width="17%" height=6><br />
<P align=center>Negative</P></TD><br />
<TD vAlign=top width="20%" height=6><br />
<P align=right>Total</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="27%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="17%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="20%" height=5><br />
<P></P></TD></TR><br />
<TR><br />
<TD vAlign=top width="27%" height=5><br />
<P>Tone Frequencies</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>50 (36%)</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>46 (34%)</P></TD><br />
<TD vAlign=top width="17%" height=5><br />
<P align=center>41 (30%)</P></TD><br />
<TD vAlign=top width="20%" height=5><br />
<P align=right>137 (100%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="27%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="17%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="20%" height=5><br />
<P></P></TD></TR></TBODY></TABLE></P><br />
<P>Common Terms for Biotechnology<br />
<P>Three terms used to describe biotechnology and products of biotechnology were clearly used more than any others. &#8220;Genetically modified&#8221; was used in the first reference to biotechnology in 35% of the 137 articles. &#8220;Genetically engineered&#8221; was the first-reference term used in 30% of the articles, and &#8220;biotechnology&#8221; (including &#8220;biotech&#8221;) was the first-reference term in 19% of the articles. Other terms and acronyms, such as &#8220;bio-engineered,&#8221; &#8220;GMO,&#8221; and &#8220;Genetically altered&#8221; were used on first reference much less frequently.<br />
<P>Interrelationships among Issues, Tone, and Terminology<br />
<P>Issues and Tone<br />
<P>Issues and article tone appeared to have a definite relationship. The 66 socio-economic articles were noticeably polarized, with 39% having a positive tone and 35% having a negative tone. Political articles found the middle ground, with 46% being coded as neutral. Fifty-eight percent of the physical science articles had a positive tone.<br />
<P>Table 2<br />
<P>Relationship between issues and tone in biotechnology articles (N=137).</P><br />
<P><br />
<TABLE borderColor=#008000 cellSpacing=2 width=370 border=1><br />
<TBODY><br />
<TR><br />
<TD vAlign=top width="16%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="27%" height=5><br />
<P align=center>Socio-Economic</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>Political</P></TD><br />
<TD vAlign=top width="39%" colSpan=2 height=5><br />
<P align=center>Physical Science</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="16%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="27%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="39%" colSpan=2 height=5><br />
<P></P></TD></TR><br />
<TR><br />
<TD vAlign=top width="16%" height=5><br />
<P>Positive</P></TD><br />
<TD vAlign=top width="27%" height=5><br />
<P align=center>26 (39%)</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>13 (25%)</P></TD><br />
<TD vAlign=top width="39%" colSpan=2 height=5><br />
<P align=center>11 (58%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="16%" height=5><br />
<P>Neutral</P></TD><br />
<TD vAlign=top width="27%" height=5><br />
<P align=center>17 (26%)</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>24 (46%)</P></TD><br />
<TD vAlign=top width="39%" colSpan=2 height=5><br />
<P align=center>5 (26%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="16%" height=5><br />
<P>Negative</P></TD><br />
<TD vAlign=top width="27%" height=5><br />
<P align=center>23 (35%)</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>15 (29%)</P></TD><br />
<TD vAlign=top width="39%" colSpan=2 height=5><br />
<P align=center>3 (16%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>Totals</P></TD><br />
<TD vAlign=top width="27%" height=5><br />
<P align=center>66 (100%)</P></TD><br />
<TD vAlign=top width="18%" height=5><br />
<P align=center>52 (100%)</P></TD><br />
<TD vAlign=top width="39%" colSpan=2 height=5><br />
<P align=center>19 (100%)</P></TD></TR></TBODY></TABLE></P><br />
<P>Tone and Terminology<br />
<P>A clear majority (54%) of the articles employing &#8220;biotechnology&#8221; as the first reference to the technology had a positive tone; 23% were negative, and 23% were neutral. Articles using the term &#8220;genetically engineered&#8221; as the first reference to biotechnology also were predominantly positive, with 46% positive, 32% neutral, and 22% negative. Nearly half (48%) of the articles using &#8220;genetically modified&#8221; were neutral, yet 29% were negative and only 23% were positive.<br />
<P>Table 3<br />
<P>Relationships between tone and terminology in biotechnology articles (N=137).</P><br />
<P><br />
<TABLE borderColor=#008000 cellSpacing=2 width=429 border=1><br />
<TBODY><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>Positive </P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>Neutral</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>Negative </P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>Totals</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Biotech/Biotechnology</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>14 (54%)</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>6 (23%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>6 (23%)</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>26 (100%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Genetically engineered</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>19 (46%)</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>13 (32%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>9 (22%)</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>41 (100%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Genetically modified</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>11 (23%)</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>23 (48%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>14 (29%)</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>48 (100%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Other </P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>6 (27%)</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>4 (18%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>12 (55%)</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>22 (100%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>GMO</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>2</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>3</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Transgenic</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>1</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Cloning/cloned </P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>1</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Bio-engineered</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>2</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>6</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>9</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Gene-/Genetically altered</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>2</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>4</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>7</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="35%" height=5><br />
<P>Genetic Technology</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="15%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="16%" height=5><br />
<P align=right>1</P></TD></TR></TBODY></TABLE></P><br />
<P>Terminology and Issues<br />
<P>In articles that focused on socio-economic issues, &#8220;genetically engineered&#8221; was the most popular choice of first-reference terminology. Thirty-three percent of the socio-economic articles used &#8220;genetically engineered&#8221; upon first reference. &#8220;Genetically modified&#8221; was also a common first-reference term in socio-economic articles (30%). &#8220;Biotechnology&#8221; was used in 21% of the articles. &#8220;Bio-engineered&#8221; and &#8220;genetically altered,&#8221; which were identified in only a few articles, were used most often in socio-economic pieces (7% and 6%, respectively).<br />
<P>Articles about political issues were more uniform in their use of terminology. Forty-eight percent of the political articles used &#8220;genetically modified&#8221; as the first reference to the technology.<br />
<P>&#8220;Genetically engineered&#8221; was the choice term by journalists who wrote physical science articles. Fifty-two percent of the physical science articles first referred to biotechnology with this term.<br />
<P>Table 4.<br />
<P>Relationship between terminology and issues in biotechnology articles.</P><br />
<P><br />
<TABLE borderColor=#008000 cellSpacing=2 width=361 border=1><br />
<TBODY><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P></P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>Socio-</P><br />
<P align=center>Economic</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>Political</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>Physical </P><br />
<P align=center>Science</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Biotech/Biotechnology</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>14 (21%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>9 (17%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>3 (16%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Genetically engineered</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>22 (33%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>9 (17%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>10 (53%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Genetically modified</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>20 (30%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>25 (48%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>3 (16%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Other </P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>10 (15%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>9 (17%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>3 (16%)</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>GMO</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Transgenic</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>0</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Cloning/cloned </P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Bio-engineered</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>5</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>4</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>0</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Gene-/Genetically altered</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>4</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>2</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P>Genetic Technology</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>0</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>1</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>0</P></TD></TR><br />
<TR><br />
<TD vAlign=top width="42%" height=5><br />
<P align=right>Totals</P></TD><br />
<TD vAlign=top width="21%" height=5><br />
<P align=center>66 (100%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>52 (100%)</P></TD><br />
<TD vAlign=top width="19%" height=5><br />
<P align=center>19 (100%)</P></TD></TR></TBODY></TABLE></P><br />
<P class=MsoNormal style="LINE-HEIGHT: 200%"><B style="mso-bidi-font-weight: normal">Conclusions and Discussion<?XML:NAMESPACE PREFIX = O /><O:P></O:P></B></P><br />
<P>The findings point to some important preliminary concepts regarding the interrelationships between journalistic tone, issues, and terminology that deserve more thought and investigation. This qualitative study, performed from the perspective of inductive thought, could set the stage for further analysis with a larger, more representative sample and a more deductive approach. </P><br />
<P>The characterization of the tone of biotechnology coverage examined in this study is congruent with recent content analysis studies claiming that coverage by U.S. journalists has been neutral, if not positive (IFIC, 2001).<SPAN style="mso-spacerun: yes">? </SPAN>During the analysis, it became evident that some publications?the regional news and national trade publications<SPAN style="mso-spacerun: yes">? </SPAN>specifically?were more likely to publish biotechnology articles with positive or at least neutral tones.<SPAN style="mso-spacerun: yes">? </SPAN>Though differences among publications in terms of tone and issues covered was beyond the scope of this study, more work will be done to describe this interrelationship. </P><br />
<P>The biotechnology lexicon among the authors of the articles in this study, was not as disorganized as some may have predicted.<SPAN style="mso-spacerun: yes">? </SPAN>The terms ?genetically modified,? ?genetically engineered,? and ?biotechnology? were clearly the most common first-reference terms, and therefore are likely the most recognizable to consumers.<SPAN style="mso-spacerun: yes">? </SPAN>Additionally, during the data analysis, it became clear that individual publications were relatively consistent in their use of first-reference terminology (though many articles employed alternative terms deeper into the story).<SPAN style="mso-spacerun: yes">? </SPAN>Whether this represents consistent choices by copy editors or authors is uncertain, and could also be the focus of more investigation. </P><br />
<P>Terminology?s relationship to tone is evident in the findings.<SPAN style="mso-spacerun: yes">? </SPAN>However, the causality of the relationship remains unclear and will require more investigation.<SPAN style="mso-spacerun: yes">? </SPAN>?Genetically modified? appears to have been the most popular term among journalists, and it also appears to have been the term of choice for journalists who wrote neutral stories about biotechnology.<SPAN style="mso-spacerun: yes">? </SPAN>Meanwhile, ?genetically engineered,? the second most popular term, appeared as the first-term reference to biotechnology in the highest percentage of physical science articles, which were mostly positive.<SPAN style="mso-spacerun: yes">? </SPAN>However, ?biotechnology? was clearly related to the highest percentage of positive stories.<SPAN style="mso-spacerun: yes">? </SPAN>This supports Levy and Derby?s (2000) findings that ?biotechnology? is the least negative term and that though ?genetically engineered? is descriptive enough, ?genetically modified? may be a gentler, less emotionally charged term.<SPAN style="mso-spacerun: yes">? </SPAN>Because of its popularity in mass media and because it seems to be the most benign of the three most popular terms, ?genetically modified? and closely related terminology should serve both communicators and survey researchers who are searching for a neutral term, recognizable by consumers, to use in reference to many types of biotechnology and biotechnology products.<SPAN style="mso-spacerun: yes">? </SPAN>When the situation calls for a more positive term, ?biotechnology? might be the best fit.<SPAN style="mso-spacerun: yes">? </SPAN>Also, for those searching for a term with more negative connotations, the less popular and more negatively-charged terms ?bio-engineered? and ?genetically altered? might serve as appropriate choices.<SPAN style="mso-spacerun: yes">? </SPAN></P><br />
<P>Differences in journalists? terminology choices among articles with focuses on socio-economic, political, and physical science issues also were evident.<SPAN style="mso-spacerun: yes">? </SPAN>Physical science writers most commonly chose the term ?genetically engineered,? which was found to be less positive than ?biotechnology.?<SPAN style="mso-spacerun: yes">? </SPAN>However, physical science articles were often supportive of the technology, which presents a slight contradiction and raises the question of whether science journalists are aware of the connotations of the terminology they choose.<SPAN style="mso-spacerun: yes">? </SPAN>In political articles, which were relatively neutral, journalists used ?genetically modified? nearly three times as often as any other term.<SPAN style="mso-spacerun: yes">? </SPAN>This finding supports the description of ?genetically modified? as a relatively neutral term.<SPAN style="mso-spacerun: yes">? </SPAN>In socio-economic articles, which were obviously polarized, ?genetically engineered? was used nearly as commonly as ?genetically modified.?<SPAN style="mso-spacerun: yes">? </SPAN>Whether the use of these terms is directly related to the polarity of socio-economic articles is unclear and should be the focus of further analysis.</P><br />
<P>Finally, because this study was preliminary and exploratory, some methodological lessons became evident during the data collection and anaylsis phases. Choices of keywords used to identify biotechnology-related articles in various databases possibly influenced the findings. It was apparent that journalists normally used a few&#8211;sometimes several&#8211;different terms to refer to the technology after the first reference (though the first-reference terms hold the most rheotical weight) so a more inclusive keyword search string would add reliability to similar studies of this nature.<SPAN style="mso-spacerun: yes">? </SPAN></P><br />
<P>This study indicates that relationships may exist among tone, issues, and terminology in journalistic articles about agricultural biotechnology.<SPAN style="mso-spacerun: yes">?? </SPAN>A better understanding of these relationships is necessary for journalists and public communicators in all facets of the issue as well as for public perception researchers in academe and industry.<SPAN style="mso-spacerun: yes">? </SPAN>More studies on these relationships are necessary to support or refute the conclusions of this exploratory study and to help communications practitioners and researchers make informed decisions in their choices of terminology representing biotechnology and products resulting from biotechnology. </P><br />
<P class=MsoNormal style="LINE-HEIGHT: 200%; MARGIN-RIGHT: 0.5in"><B style="mso-bidi-font-weight: normal">References<O:P></O:P></B></P><br />
<P>Cohen, J. (1960).<SPAN style="mso-spacerun: yes">? </SPAN>A coefficient of agreement for nominal scales.<SPAN style="mso-spacerun: yes">? </SPAN><I style="mso-bidi-font-style: normal">Educational and Psychological Measurement, 20 </I>(1), 37-46. </P><br />
<P>Gaskell, G., Bauer, M.W., Durant, J. &#038; Allum, N.C. (1999, July 17). Worlds Apart?<SPAN style="mso-spacerun: yes">? </SPAN>The Reception of Genetically Modified Foods in Europe and the U.S. <I style="mso-bidi-font-style: normal">Science, 285</I>, (5426). </P><br />
<P>Gunter, B., Kinderlerer, J., &#038; Beyleveld, D. (1999, June). The media and public understanding of biotechnology. <I style="mso-bidi-font-style: normal">Science Communication, 20</I>(4), 373-394.</P><br />
<P>Hoban, T.J. &#038; Kendall, P.A. (1996). Anticipating public reaction to the use of genetic engineering infant nutrition. <I style="mso-bidi-font-style: normal">American Journal of Clinical Nutrition, 63</I>, 657S-662S.</P><br />
<P>International Food Information Council Foundation [IFIC].<SPAN style="mso-spacerun: yes">? </SPAN>(2001, November). Most Americans can articulate expected benefits of food biotechnology.<SPAN style="mso-spacerun: yes">? </SPAN>Retrieved March 15, 2002 from <A href="http://ific.org/" target=_blank>http://ific.org</A> </P><br />
<P>Levy, A.S. &#038; Derby, B.M.<SPAN style="mso-spacerun: yes">? </SPAN>(2000, October).<SPAN style="mso-spacerun: yes">? </SPAN>Report on consumer focus groups on biotechnology.<SPAN style="mso-spacerun: yes">? </SPAN>U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition, Office of Scientific Analysis and Support.<SPAN style="mso-spacerun: yes">? </SPAN>Retrieved June 21, 2002 from <A href="http://www.cfsan.fda.gov/~comm/biorpt.html" target=_blank>http://www.cfsan.fda.gov/~comm/biorpt.html</A> </P><br />
<P>Lien, Nai-Hwa. (2001).<SPAN style="mso-spacerun: yes">? </SPAN>Elaboration Likelohood Model in consumer research:<SPAN style="mso-spacerun: yes">? </SPAN>A Review.<SPAN style="mso-spacerun: yes">? </SPAN><I style="mso-bidi-font-style: normal">Proceedings of the National Science Council, 11</I> (4), 301-310. </P><br />
<P>Marks, L.A.<SPAN style="mso-spacerun: yes">? </SPAN>(2001).<SPAN style="mso-spacerun: yes">? </SPAN>Communicating about agrobiotecnology.<SPAN style="mso-spacerun: yes">? </SPAN><I style="mso-bidi-font-style: normal">AgBioFourm, 4</I> (3-4), 152-154. </P><br />
<P>Priest, S.H. (2000).<SPAN style="mso-spacerun: yes">? </SPAN>U.S. public opinion divided over biotechnology?<SPAN style="mso-spacerun: yes">? </SPAN><I style="mso-bidi-font-style: normal">Nature Biotechnology, 18,</I> 939-942. </P><br />
<P>Sohan, D.E., Waliczek, T.M., &#038; Briers, G.E.<SPAN style="mso-spacerun: yes">? </SPAN>(2002).<SPAN style="mso-spacerun: yes">? </SPAN>Knowledge, attitudes, and perceptions regarding biotechnology among college students<I style="mso-bidi-font-style: normal">.<SPAN style="mso-spacerun: yes">? </SPAN>Journal of Natural Resources and Life Science Education, 31</I>, 5-11.</P><br />
<P>Vestal, T.A. &#038; Briers, G.E. (2000). Exploring knowledge, attitudes and perceptions of newspaper journalists in metropolitan markets in the United States regarding food biotechnology. <I style="mso-bidi-font-style: normal">Journal of Agricultural Education, 41</I>(4), 134-144. </P><br />
<P>Wansink, B. &#038; Kim, J. (2001).<SPAN style="mso-spacerun: yes">? </SPAN>The marketing battle over genetically modified foods:<SPAN style="mso-spacerun: yes">? </SPAN>False assumptions about consumer behavior.<SPAN style="mso-spacerun: yes">? </SPAN><I style="mso-bidi-font-style: normal">American Behavioral Scientist, 44 </I>(8), 1405-1417. </P><br />
<P>&nbsp; </P></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=1221/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[GMO] Trends In Consumer Attitudes About Agricultural Biotechnology</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=1220</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=1220#comments</comments>
		<pubDate>Sun, 01 Nov 2009 15:17:05 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[GMO]]></category>
		<category><![CDATA[과학기술 · 생의학]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[Thomas J. Hoban]]></category>
		<category><![CDATA[생명공학]]></category>
		<category><![CDATA[소비자 인식]]></category>
		<category><![CDATA[유전자조작]]></category>
		<category><![CDATA[홍보전략]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=1220</guid>
		<description><![CDATA[유전자조작 산업(생명공학업계)을 위해 광범위한 여론조사를 수행하고 있는 노스캐롤라이나 주립대학교 사회학과 교수 톰 허번의 논문입니다.그는 1998년 6월 생명공학산업기구 회의에서 일반 대중의 무지를 조롱하며 &#8220;많은 미구의 소비자들은 종자가 농업과 관련이 [...]]]></description>
				<content:encoded><![CDATA[<p><DIV id=ArticleTitle>유전자조작 산업(생명공학업계)을 위해 광범위한 여론조사를 수행하고 있는 노스캐롤라이나 주립대학교 사회학과 교수 톰 허번의 논문입니다.<BR><BR>그는 1998년 6월 생명공학산업기구 회의에서 일반 대중의 무지를 조롱하며 &#8220;많은 미구의 소비자들은 종자가 농업과 관련이 있다는 사실을 모를 것이다. 어쩌면 그들은 농장이 농업과 관계가 있다는 사실조차 모를 것이다.&#8221;는 말을&nbsp;한 바 있습니다. 그는 이런 대중의 무지를 산업계가 소비자들을 &#8216;전향적으로 교육할 수 있는&#8217; 엄청난 기회로 보고 있습니다. <BR><BR><FONT size=2><STRONG>Trends In Consumer Attitudes About Agricultural Biotechnology</STRONG></FONT><BR><BR></DIV><br />
<DIV class=ArticleAuthor>Thomas J. Hoban</DIV><br />
<DIV class=ArticleAffiliation>North Carolina State University-Raleigh<BR></DIV><!-- TEXT BEGINS: ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ --><BR>출처 : <A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm">http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm</A><BR><BR>The benefits of agricultural biotechnology have been promised for almost two decades. That promise is becoming reality. A growing number of American farmers are raising crops developed through biotechnology that are protected from insects and require fewer pesticides. As with other commodities, these grains (such as corn and soybeans) are blended into processed foods. That use of biotechnology will be invisible to consumers. In the future, biotechnology will lead to more obvious improvements in the nutritional profiles and other qualities of many foods.<br />
<P>In light of these developments, industry and government need a better understanding of consumers&#8217; acceptance of biotechnology, especially in Europe. Despite the potential benefits, agricultural biotechnology has been controversial in some European countries. However, the American and Canadian markets have remained calm as the foods containing ingredients developed through biotechnology have started arriving in stores. The full benefits of biotechnology will only be realized if consumers and the food industry accept the use of these new technologies as safe and beneficial. This paper reviews several major research studies to provide a brief overview of international and temporal trends in consumers&#8217; awareness of, and attitudes about, agricultural biotechnology.<br />
<P>The main results come from several major United States (US) telephone surveys that I and others have developed to examine public perceptions of agricultural biotechnology (<A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R7">Hoban &#038; Kendall, 1993</A>; <A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R4">Hoban, 1996a</A>; <A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R6">Hoban &#038; Katic 1998</A>). Selected results are also presented from two US surveys conducted in 1995 and 1996 by the Food Marketing Institute (<A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R1">Food Marketing Institute [FMI], 1996</A>). Sample sizes ranged from 1,003 to 1,228 respondents. The European survey results come from interviews conducted with a sample of 12,849 European consumers for the Food Marketing Institute (<A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R3">Hoban, 1997</A>). Results of Japanese research will also be considered (<A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R5">Hoban, 1996b</A>).<br />
<P>This paper will also highlight, in a general way, selected results from several major surveys on public attitudes and knowledge of biotechnology conducted between 1996 and 1998. These surveys reflect the views of more than 18,000 people from 15 European countries, as well as in the United States (<A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R9">Wagner <I>et al</I>., 1997</A>; <A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R8">Hoban &#038; Miller, 1998</A>). Collectively these represent the largest such effort ever undertaken. More information on those surveys will be available soon. The random samples for these studies are representative of the countries.<br />
<P><B>Consumer Acceptance Of Biotechnology</B><br />
<P>Regardless of how we measure consumer perceptions, the surveys described above document that between two thirds and three quarters of American respondents are positive about plant biotechnology. Most people feel they either have benefited, or will benefit, from biotechnology. Consumers will accept foods when they recognize a benefit. For three years (1992, 1994, and 1998), we have asked American consumers whether they supported or opposed agricultural biotechnology. The results have been identical—just over 70 percent expressed support. This support is highest among men and people with more formal education.<br />
<P>Most people will buy new varieties of fruits and vegetables that have better flavor or are protected from insect damage with reduced use of pesticides. American surveys between 1995 and 1997 have shown that most consumers recognize the benefits of biotechnology and are willing to buy food developed through biotechnology. Results of surveys conducted in 1995 show clear differences among countries in consumers&#8217; willingness to buy produce developed through biotechnology. Over half of the consumers in all but three countries reported a willingness to buy a new variety of produce (such as a potato or tomato) that had been modified by biotechnology to be protected from insect damage. Only German and Austrian consumers were clearly opposed to plant biotechnology. Results for a similar question about &#8220;better tasting or fresher&#8221; produce show a similar pattern, but acceptance is somewhat lower.<br />
<P>It is important to put perceived risks of biotechnology into an appropriate context (compared to other potential food safety concerns). The FMI surveys in the US and Europe asked consumers to rate the relative severity of a range of potential food safety risks. American consumers expressed the most concern about microbial contamination and pesticides and moderate concern over several other risks. Fewer than one in five saw biotechnology as a serious food safety risk (the lowest of any issue discussed). The pattern is similar in Europe, where genetic engineering was perceived to be the eighth in the list (perceived as just slightly more risky than artificial colors).<br />
<P>Different applications of biotechnology vary considerably in terms of their acceptance. Consumers see considerable value in human genetic testing and the development of new medicines to combat disease. They are also quite supportive of the use of biotechnology to develop new types of insect-resistant crop plants. However, consumers are less likely to accept the use of biotechnology with animals (even to enhance human health). This presents challenges to use of biotechnology for the development and commercialization of new livestock applications.<br />
<P><B>Educational Needs And Opportunities</B><br />
<P>The extent to which people are aware of an issue reflects the general level of importance or relevance. Respondents have been asked to rate their own understanding and awareness of biotechnology in the various surveys. The results from the US show virtually no change in consumer awareness of biotechnology between 1992 and 1996. Only about one third of US consumers had heard or read a lot or something about biotechnology. Awareness in the US rose significantly in 1997, with the media attention to the cloning of a sheep.<br />
<P>Awareness in other countries varies considerably. In 1995, awareness was very high in Germany, Austria, Denmark, and Japan. It was also quite high in Canada, the Netherlands, and three other Scandinavian countries. The other nine European countries reported relatively lower levels of awareness, with the lowest levels coming from the southern European countries. During the last few years, awareness appears to have risen in Europe. This has been fueled by increased media coverage. There is evidence that increased levels of awareness are not direct reflections of increased levels of knowledge about biotechnology from a scientific perspective.<br />
<P>Survey results show that providing factual information increases consumer acceptance (at least in the US and Japan). Sources of information vary in terms of their credibility. People in these countries have the most trust in independent health and scientific experts. In particular, we find that acceptance increases significantly when American consumers learn that groups such as the American Medical Association, the Food and Drug Administration (FDA), and other independent scientific experts have determined that the foods from biotechnology are safe. However, Europe is a different story. The European public expresses the most trust in consumer and environmental groups. Trust in government and industry is much lower than in the US<br />
<P>People do tend to express interest in learning more about biotechnology. They want to know why it is used, as well as its safety, benefits, and other issues. People will ask the same basic questions about biotech-produced food as they ask about foods available now. At the top of the list will be &#8220;How does it taste and how much does it cost?&#8221; Then people will want to know about nutrition, safety, and cooking techniques. How the products (or its ingredients) were developed will be irrelevant for the vast majority of American consumers. The European consumer reaction appears to be somewhat different, with more concern over the environmental, political, and social impacts of agricultural biotechnology.<br />
<P><B>Labeling Issues</B><br />
<P>The most challenging issue facing the food industry involves labeling. To avoid confusion, the FDA has determined that a food product should be labeled as a product of biotechnology <I>only</I> if it has been changed in some significant way. This policy ensures product availability, while providing consumers with relevant information about food safety or compositional changes. A national survey of American consumers conducted in 1997 found that over three quarters of consumers supported the FDA labeling policy (<A href="http://www.agbioforum.org/v1n1/v1n1a02-hoban.htm#R6">Hoban &#038; Katic, 1998</A>).<br />
<P>People claim to pay a lot of attention to food labels, especially for nutrition information. In the case of biotechnology, it might make sense to label fresh produce developed through biotechnology if there is a clear difference (such as longer shelf life or reduced pesticides.) However, the labeling of processed foods presents a number of logistical challenges and costs for everyone involved. For example, American consumers report little need to label a bottle of ketchup that includes biotech tomatoes in addition to traditionally bred varieties. In fact, most people don&#8217;t even understand that different varieties of vegetables or fruits are currently blended during processing. In addition, consumers are not willing to pay extra to have foods labeled as a product of biotechnology (especially when this information has no meaning).<br />
<P>It is important to realize that labeling is not education. In the US, the FDA has determined that information on food labels should be simple, meaningful, and consistent. Labels on foods that have not been changed in any way through the use of biotechnology would likely be perceived as alarming and irrelevant. Consumers want and deserve meaningful choice (that is, among products that are truly different). Most do not want to be confronted by unnecessary duplication of product offerings.<br />
<P><B>Conclusions And Implications</B><br />
<P>Results of this and other research indicates that biotechnology will not become an issue for most American, Canadian, or Japanese consumers. American consumers (as well as many others around the world) are optimistic about biotechnology. They will accept the products if they see a benefit to themselves or society, and if the price is right! Their response to foods developed with biotechnology is the same as for other foods. Taste, nutrition, price, safety, and convenience are the major issues. Biotechnology will remain an issue in some parts of Europe, at least over the short term. However, the opposition there should fade with time, as more products arrive on the market that are clearly beneficial to consumers.<br />
<P>Further analysis of the survey results shows that consumer acceptance of biotechnology is driven by a number of interrelated factors. First, there needs to be a demonstrable benefit from the application, as well as an acceptable (that is, low) level of risk. It is also very important that the applications are viewed as morally acceptable to society. People need confidence in third party experts.<br />
<P>Given the low levels of public understanding, more education will be important as more new products become available. The public needs to recognize that the products of biotechnology have benefits. They should come to believe that the applications of biotechnology are morally acceptable and safe. The ethics of feeding the world while protecting the environment could also influence some consumers&#8217; attitudes. It will also be important to ensure that government regulations are in place to minimize any risks.<br />
<P>Additional analysis of the latest international surveys will be helpful. This would help to systematically evaluate the factors that influence public attitudes, as well as the causes and nature of differences among the countries. Additional research on this topic will also be important. In particular it would be very helpful to have a systematic comparison between public attitudes and those of key leaders from government, industry, and other areas.<br />
<P>Several reasons can be suggested for the differences observed between various countries. Media coverage and activist opposition has been most pronounced in those countries where survey respondents were more negative. In general, controversies have been more visible in Germany, Austria, Sweden, and Denmark than in other countries. The benefits of biotechnology have not generally been recognized, while the potential risks have been emphasized. There also are a number of fundamental cultural differences (especially between some of the European countries and North America). These and other issues need more careful attention.<br />
<P><A name=REFS></A><B>References</B><br />
<P><A name=R1></A>Food Marketing Institute. (1996). <I>Trends in the United States: Consumer attitudes and the supermarket.</I><B> </B>Washington, D.C.: Food Marketing Institute.<br />
<P><A name=R2></A>Food Marketing Institute. (1995). <I>Trends in Europe: Consumer attitudes and the supermarket.</I><B> </B>Washington, D.C.: Food Marketing Institute.<br />
<P><A name=R3></A>Hoban, T. J. (1997). Consumer acceptance of biotechnology: An International perspective. <I>Nature Biotechnology</I>, <I>15</I>, 232-234.<br />
<P><A name=R4></A>Hoban, T. J. (1996a). Trends in consumer attitudes about biotechnology. <I>Journal of Food Distribution Research</I>, <I>27</I>(1), 1-10.<br />
<P><A name=R5></A>Hoban, T. J. (1996b).<I> </I>How Japanese consumers view biotechnology. <I>Food Technology</I>, <I>50</I>(7), 85-88.<br />
<P><A name=R6></A>Hoban, T. J. &#038; Katic, L. (1998). American consumer views on biotechnology. <I>Cereal Foods World</I>, <I>43</I>(1), 20-22.<br />
<P><A name=R7></A>Hoban, T. J. &#038; Kendall, P.A. (1993). <I>Consumer attitudes about food biotechnology.</I><I> </I>Raleigh, N.C.: North Carolina Cooperative Extension Service.<br />
<P><A name=R8></A>Hoban, T. J. &#038; Miller, J.D. (1998). Consumer images and impressions. Paper presented at the <I>Annual Meetings of the American Association for the Advancement of Science</I>. Philadelphia, P.A.<br />
<P><A name=R9></A>Wagner, W., <I>et al</I>. (1997, June 26). Europe ambivalent on biotechnology [Commentary]. <I>Nature</I>, <I>387</I>, pp. 845-847.<br />
<P><!-- TEXT ENDS ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ --><br />
<HR><br />
<BR><br />
<OL><br />
<P><br />
<LI value=1><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C09841">Japanses consumers&#8217; awareness and attitudes about biotechnology</A><BR>By: Hoban, T.J.<BR>Published: Jun 1998<BR><br />
<P></P><br />
<P></P><br />
<LI value=2><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C10076">Food industry innovation: efficient consumer response</A><BR>By: Hoban, T.J.<BR>Published: Jun 1998<BR><br />
<P></P><br />
<P></P><br />
<LI value=3><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C10089">Cognitive determinants of risk perceptions associated with biotechnology</A><BR>By: Hoban, T.J.; Urban, D.<BR>Published: 1997<BR><br />
<P></P><br />
<P></P><br />
<LI value=4><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C10108">Promotion &#038; advertising for Kentucky&#8217;s direct markets</A><BR>By: Stegelin, Forrest; Weckman, R.; Hoban, T.J.; Strang, J.<BR><br />
<P></P><br />
<P></P><br />
<LI value=5><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C15855">Consumer acceptance of biotechnology: an international perspective</A><BR>By: Hoban, T.J.<BR>Published: 1997<BR><br />
<P></P><br />
<P></P><br />
<LI value=6><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C15889">The construction of food biotechnology as a social issue</A><BR>By: Hoban, T.J.<BR>Published: 1995<BR><br />
<P></P><br />
<P></P><br />
<LI value=7><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C15890">American consumers&#8217; awareness and acceptance of biotechnology</A><BR>By: Hoban, T.J.<BR>Published: 2001<BR><br />
<P></P><br />
<P></P><br />
<LI value=8><A href="http://web.library.uiuc.edu/asp/agx/acdc/view.asp?ID=C16965">Anticipating public reaction to the use of genetic engineering infant nutrition</A><BR>By: Hoban, T.J.; Kendall, P.A.<BR>Published: 1996<BR><br />
<P></P></LI></OL></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=1220/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
